Multidisciplinary consultation for patients with systemic lupus erythematosus
Official title: Cohort Follow-up of Systemic Lupus Erythematosus Within the Framework of the Multidisciplinary Consultation at the CHRU of Brest
Run by University Hospital, Brest · NCT04320680 · Data updated 2026-11-12
This study is trying to see how a team of specialists can help people with lupus by closely checking their health and gathering information to improve treatment.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 80 Years |
| Sex | All |
| Enrollment | 150 (estimated) |
| Sponsor | University Hospital, Brest Academic / other |
| Locations | 1 site (Brest) |
| Status | Recruiting |
| Started | October 13, 2020 |
| Main results expected | May 13, 2025 |
| Study ends | May 13, 2025 |
| Registry record updated | February 4, 2025 |
| Trial ID | NCT04320680 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults over 18 years old who are attending the multidisciplinary consultation in Brest for systemic lupus erythematosus.
✕Probably not a fit
Patients under 18 years old, those who refuse to participate, or individuals under legal protection may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study involves the diagnosis and follow-up of patients with systemic lupus erythematosus at a multidisciplinary consultation in Brest, France. Participants will undergo a comprehensive clinical examination, along with biological and immunological blood tests, and may receive cutaneous or renal biopsies if necessary. Additionally, patients with joint involvement will have X-rays taken at the start and annually for five years, along with ultrasonographic examinations of joints and salivary glands as needed. The aim is to create a detailed lupus patient cohort for better understanding and management of the disease.
Why it matters
Potential benefit: If successful, this study could lead to improved diagnosis and management strategies for patients with systemic lupus erythematosus.
How similar studies have gone: While there have been studies focusing on lupus management, this specific multidisciplinary approach is relatively novel and may provide new insights.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * women or men, more than 18 years old, coming to the multidisciplinary consultation in brest ( France). * With written consentment Exclusion Criteria: * patients less than 18 years old * refusing to participate * Under legal protection
Where it's running
-
CHRU de Brest
Brest, France Recruiting
Study contacts
- Study coordinator: sandrine jousse joulin, MD
- Email: sandrine.jousse-oulin@chu-brest.fr
- Phone: +33 2 98 34 72 68
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Effects of anifrolumab on arterial inflammation in SLE patients
This study tests whether anifrolumab can reduce blood vessel inflammation in people with active systemic lupus erythematosus.
-
Home urine testing for people with lupus
Participants with lupus will try weekly home urine tests in addition to usual care to see if this helps monitor kidney health over a year.
-
CR-402 treatment for refractory autoimmune disease
This study tests CRT-402, a CD19-targeted CAR-T therapy, in adults with active, treatment-resistant autoimmune diseases like SLE, systemic sclerosis, and inflammatory myopathy to see if it is safe and capable of helping control disease.
-
ATG-201 in adults with autoimmune diseases
This early, open-label study tests ATG-201 in adults with autoimmune diseases to see if it is safe and tolerable, and to get initial clues about how the body handles the drug and its effects.
-
Biomarker tests in adults with lupus to see how kidney disease changes over time
Researchers will follow adults with lupus to see if blood and urine biomarkers can predict kidney involvement, flares, and treatment responses during routine care.
-
Sirolimus added to standard therapy for adults with SLE-associated immune thrombocytopenia
This trial tests whether adding sirolimus to usual treatment helps adults with SLE-related immune thrombocytopenia see their platelet counts improve.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.